Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie, N. Engl. J. Med, vol.338, pp.1272-1278, 1998. ,
Novel agents and approaches for advanced renal cell carcinoma, J. Urol, vol.188, pp.707-715, 2012. ,
Immune checkpoint inhibitors in advanced renal cell carcinoma: Experience to date and future directions, Ann. Oncol. Off. J. Eur. Soc. Med Oncol, vol.28, pp.1484-1494, 2017. ,
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma, N. Engl. J. Med, vol.380, pp.1103-1115, 2019. ,
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma, N. Engl. J. Med, vol.380, pp.1116-1127, 2019. ,
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): A randomised, Lancet Oncol, vol.20, pp.297-310, 2019. ,
Systematic identification of genomic markers of drug sensitivity in cancer cells, Nature, vol.483, pp.570-575, 2012. ,
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, vol.483, pp.603-607, 2012. ,
The NCI60 human tumour cell line anticancer drug screen, Nat. Rev. Cancer, vol.6, pp.813-823, 2006. ,
An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules, Cell, vol.154, pp.1151-1161, 2013. ,
Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines, Mol. Cancer Ther, vol.9, pp.1451-1460, 2010. ,
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response, Curr. Opin. Genet. Dev, vol.24, pp.114-119, 2014. ,
Prospective derivation of a living organoid biobank of colorectal cancer patients, Cell, vol.161, pp.933-945, 2015. ,
, Landscape of Pharmacogenomic Interactions in Cancer. Cell, vol.166, pp.740-754, 2016.
Organotypic slice cultures of human gastric and esophagogastric junction cancer, Cancer Med, vol.5, pp.1444-1453, 2016. ,
Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments, Neuro Oncol, vol.15, pp.670-681, 2013. ,
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer, Mol. Cancer Ther, vol.14, pp.1504-1516, 2015. ,
Organoid cultures for the analysis of cancer phenotypes, Curr. Opin. Genet. Dev, vol.24, pp.68-73, 2014. ,
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery, Cell Chem. Biol, vol.24, pp.1092-1100, 2017. ,
Xenograft and organoid model systems in cancer research, EMBO J, vol.38, 2019. ,
Cerebral organoids model human brain development and microcephaly, Nature, vol.501, pp.373-379, 2013. ,
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine, vol.7, pp.462-477, 2017. ,
Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma, Oncotarget, vol.7, pp.59336-59359, 2016. ,
Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine, Front. Oncol, vol.7, issue.2, 2017. ,
Analyses of repeated failures in cancer therapy for solid tumors: Poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs, Clin. Transl. Med, vol.7, issue.11, 2018. ,
Preclinical predictors of anticancer drug efficacy: Critical assessment with emphasis on whether nanomolar potency should be required of candidate agents, J. Pharmacol. Exp. Ther, vol.341, pp.572-578, 2012. ,
Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment, Curr. Top. Microbiol. Immunol, 2019. ,
Predicting cancer drug response: Advancing the DREAM, Cancer Discov, vol.5, pp.237-238, 2015. ,
Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations, Virchows Arch, vol.450, pp.503-512, 2007. ,
Modeling tissue-specific signaling and organ function in three dimensions, J. Cell. Sci, vol.116, pp.2377-2388, 2003. ,
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors, Proc. Natl. Acad. Sci, vol.107, pp.8352-8356, 2010. ,
Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project, 2017. ,
Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma, Sci. Rep, vol.9, p.2133, 2019. ,
Bechmann, I. Slice cultures from head and neck squamous cell carcinoma: A novel test system for drug susceptibility and mechanisms of resistance, Br. J. Cancer, vol.110, pp.479-488, 2014. ,
Using pancreas tissue slices for in situ studies of islet of Langerhans and acinar cell biology, Nat. Protoc, vol.9, pp.2809-2822, 2014. ,
Hypoxia pathways and cellular stress activate pancreatic stellate cells: Development of an organotypic culture model of thick slices of normal human pancreas, PLoS ONE, vol.8, 2013. ,
Human Organotypic Cultured Cardiac Slices: New Platform For High Throughput Preclinical Human, Trials. Sci. Rep, 2016. ,
Role of IL-2 in cancer immunotherapy, Oncoimmunology, vol.5, 2016. ,
Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma, Oncotarget, vol.9, pp.30066-30078, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02176916
Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma, Cell, vol.173, pp.540-542, 2018. ,
The von Hippel-Lindau tumour suppressor protein: O 2 sensing and cancer, Nat. Rev. Cancer, vol.8, pp.865-873, 2008. ,
Targeting HIF2alpha in Clear-Cell Renal Cell Carcinoma, Cancer Cell, vol.30, pp.515-517, 2016. ,
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival, Cancer, vol.107, pp.46-53, 2006. ,
Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma, Cancer Discov, vol.9, pp.1349-1357, 2019. ,
Biomarkers as drug development tools: Discovery, validation, qualification and use, Nat. Rev. Rheumatol, vol.14, pp.354-362, 2018. ,
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma, N. Engl. J. Med, vol.378, pp.1277-1290, 2018. ,
Bommhardt, U. CD45 in human physiology and clinical medicine, Immunol. Lett, vol.196, pp.22-32, 2018. ,
PD-L1 and Survival in Solid Tumors: A Meta-Analysis, PLoS ONE, vol.10, 2015. ,
Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma, Cancer, vol.104, pp.2084-2091, 2005. ,
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.13, pp.1757-1761, 2007. ,
PD-1 blockade induces responses by inhibiting adaptive immune resistance, Nature, vol.515, pp.568-571, 2014. ,
Lim1, an embryonal transcription factor, is absent in multicystic renal dysplasia, but reactivated in nephroblastomas, Pathobiology, vol.78, pp.210-219, 2011. ,
The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma, Oncogene, vol.38, pp.60-72, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02431944
Use of CD45 gating in three and four-color flow cytometric immunophenotyping: Guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS, Cytometry, vol.50, pp.46-52, 2002. ,
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: Biology and clinical correlations, Oncogene, vol.37, pp.4639-4661, 2018. ,
Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines, Br. J. Cancer, vol.104, pp.643-652, 2011. ,
R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing, p.17, 2018. ,
Cancer: A precision approach to tumour treatment, Nature, vol.548, pp.40-41, 2017. ,
Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment, vol.6, 2017. ,